/Investor DB

JAZZ Venture Partners — 2025 Investments

2 investments dated 2025 · listed companies and verified rows first · show all

magnusmagnusmed.comin𝕏Series A · Feb 2025 · $25M

Magnus Medical develops SAINT, an FDA-cleared, accelerated form of TMS (transcranial magnetic stimulation) therapy that uses precision neuromodulation to treat Major Depressive Disorder, including treatment-resistant depression, over a 5-day course.

BiotechDigital HealthMedical DevicesMental HealthBurlingame, US

Nolan Williams(Director)Christian Gormsen(Executive Officer, Director)inVikram Lamba(Executive Officer)in

BoardXingjuan Chao(Director)inHeath Lukatch(Director)

Board seatAndrew Firlik· per SEC Form D

Co-investorsDolby Family VenturesRed Tree Venture

Eternal Healtheternal.coJan 2025

Eternal is a personalized health platform that combines wearable data, lab results, and AI coaching to deliver customized podcasts, daily texts, and in-person care for fitness, health, and longevity.

HealthtechLongevityWellness & FitnessNew York, US

Co-investorsBling CapitalFlare Capital PartnersNext VenturesTerrainTreble CapitalCourtside Ventures+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.